CAIRO PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of CPCI for the last quarter is 373.44 M EGP, and it's 11.37% higher compared to the previous quarter. The net income of Q2 24 is 61.35 M EGP.